Literature DB >> 31329971

Can serum interleukin-17 and interleukin-10 levels predict response to biologic treatments in patients with rheumatoid arthritis?

Stephen McDonald1,2, Rachel Reed3, Ivona Baricevic-Jones3, Stephanie Ling1,4, Darren Plant1,4, Anne Barton1,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31329971      PMCID： PMC6758569          DOI： 10.1093/rheumatology/kez147

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  2 in total

1.  Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints.

Authors:  T Alanärä; K Karstila; T Moilanen; O Silvennoinen; Pia Isomäki
Journal:  Scand J Rheumatol       Date:  2010-03       Impact factor: 3.641

Review 2.  The role of interleukin-17 in the pathogenesis of rheumatoid arthritis.

Authors:  Sarah L Gaffen
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592
  2 in total
  2 in total

1.  Enhanced IL-10 inhibits proliferation and promotes apoptosis of HUVECs through STAT3 signaling pathway in sepsis.

Authors:  Zuohua Xie; Bing Lin; Xinju Jia; Ting Su; Ying Wei; Jiping Tang; Chengzhi Yang; Chuanbao Cui; Jinxiang Liu
Journal:  Histol Histopathol       Date:  2021-09-16       Impact factor: 2.303

2.  IL-10/IL-10 receptor 1 pathway promotes the viability and collagen synthesis of pulmonary fibroblasts originated from interstitial pneumonia tissues.

Authors:  Hong Ye; Jiongwei Pan; Xiaoping Cai; Zhangyong Yin; Lu Li; Enhui Gong; Cunlai Xu; Hao Zheng; Zhuo Cao; Enguo Chen; Junfeng Qian
Journal:  Exp Ther Med       Date:  2022-06-15       Impact factor: 2.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.